➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Express Scripts
Merck
Dow
Harvard Business School

Last Updated: July 8, 2020

DrugPatentWatch Database Preview

Litigation Details for King Pharmaceuticals Inc. v. Intelliject Inc. (D. Del. 2011)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in King Pharmaceuticals Inc. v. Intelliject Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for King Pharmaceuticals Inc. v. Intelliject Inc. (D. Del. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-02-11 11 U.S. Patent No. 7,449,012 (the "'012 patent"; Exhibit 2) and the '432 patent (Exhibit…quot;) had listed its U.S. Patent No. 7,449,012 ("the '012 patent") in the FDA Approved … U.S. Patent No. 7,449,012 The '369 patent 1. An auto-injector… U.S. Patent No. 7,449,012 The '369 patent The needle cover… U.S. Patent No. 7,449,012 The '369 patent The needle cover External link to document
2011-02-15 15 because both cases involve the same patent, U.S. Patent No. 7,794,432. While defendants’ accused products…matters being related cases because many of the patent claim terms will read on the accused products in…2011 8 March 2012 1:11-cv-00065 830 Patent None District Court, D. Delaware External link to document
2011-01-19 3 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,794,432 B2;. (ksr) (Entered…2011 8 March 2012 1:11-cv-00065 830 Patent None District Court, D. Delaware External link to document
2011-04-12 30 complaints. In 09-652 you 22 see U.S. patent 7,449,012, then something B2. 23 UNIDENTIFIED…there is a common patent, and that is the, I will call it 16 the '012 patent, and the second case…case adds to that the '432 17 patent? Is that correct? 18 UNIDENTIFIED SPEAKER…SPEAKER: I believe it's the '432 19 patent that is common to both cases, Your Honor. 20 …UNIDENTIFIED SPEAKER: I believe the patent was 24 added to that case in November of last year. External link to document
2011-10-17 72 ORDER CONSTRUING THE TERMS OF U.S. PATENT NOS. 7,499,012; AND 7,794,432. Signed by Xhief Judge Gregory M…2011 8 March 2012 1:11-cv-00065 830 Patent None District Court, D. Delaware External link to document
2011-11-07 80 . Clemens Regarding Infringement of U.S. Patent No. 7,794,432 by King Pharmaceuticals Inc., Meridian Medical…2011 8 March 2012 1:11-cv-00065 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
McKinsey
Baxter
Dow
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.